covid19treatmentguidelines(folder)

Site
Coronavirus_Disease_2019_COVID-19_in_Children_Vuln
WHO-2019-nCoV-Sci-Brief-Children-and-adolescents-2021.1-eng
The intriguing features of COVID-19 in children and its
impact on the pandemic
1-s2.0-S018844092100148X-main
J Paediatrics Child Health - 2021 - Howard‐Jones - COVID‐19 in children I Epidemiology prevention and indirect impacts
J Paediatrics Child Health - 2021 - Howard‐Jones - COVID‐19 in children II Pathogenesis disease spectrum and management
Long covid
Factori de risc pentru covid grav
Acta Paediatrica - 2022 - Ludvigsson - Convulsions in children with COVID‐19 during the Omicron wave
Dermatological effects in covid
Multysistem inf. disease in covid
Develop Med Child Neuro - 2022 - Stafstrom - Neurological effects of COVID‐19 in infants and children
Diagnostic fara febra si fara expunere
Covid la copii cu probleme hematologice

Imunologie la copii cu covid

gastrointestinal in covid
covid la copii cu tuberculoza
Complicatii autoimune
COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Hea
https://www.mayoclinic.org/diseases-conditions/coronavirus/in-depth/coronavirus-in-babies-and-children/art-20484405
Saleem, Hajra & Rahman, Jawaria & Aslam, Nida & Murtazaliev, Salikh & Khan, Safeera. (2020). Coronavirus Disease 2019 (COV
WHO reference number: WHO/2019-nCoV/Sci_Brief/Children_and_adolescents/2021.1

https://www.scielo.br/j/jped/a/R68f5rLHYzT7TcKHFYVFZGq/?lang=en&format=pdf
Nikolopoulou GB, Maltezou HC. COVID-19 in Children: Where do we Stand? Arch Med Res. 2022 Jan;53(1):1-8. doi: 10.1016/j.a
Howard-Jones, A.R., Bowen, A.C., Danchin, M., Koirala, A., Sharma, K., Yeoh, D.K., Burgner, D.P., Crawford, N.W., Goeman, E., G
Howard-Jones, A.R., Burgner, D.P., Crawford, N.W., Goeman, E., Gray, P.E., Hsu, P., Kuek, S., McMullan, B.J., Tosif, S., Wurzel, D
Borch, L., Holm, M., Knudsen, M. et al. Long COVID symptoms and duration in SARS-CoV-2 positive children — a nationwide co
Choi JH, Choi SH, Yun KW. Risk Factors for Severe COVID-19 in Children: A Systematic Review and Meta-Analysis. J Korean M
Ludvigsson, JF. Convulsions in children with COVID-19 during the Omicron wave. Acta Paediatr. 2022; 111: 1023– 1026. doi:10
Panda M, Agarwal A, Hassanandani T. Dermatological Manifestations of COVID-19 in Children. Indian Pediatr. 2022 May 15;59
Waseem M, Shariff MA, Tay ET, Mortel D, Savadkar S, Lee H, Kondamudi N, Liang T. Multisystem Inflammatory Syndrome in Ch
Stafstrom, CE. Neurological effects of COVID-19 in infants and children. Dev Med Child Neurol. 2022; 64: 818– 829. https://doi
Roversi, M., Raucci, U., Pontrelli, G. et al. Diagnosis of COVID-19 in children guided by lack of fever and exposure to SARS-CoV-
Millen GC, Arnold R, Cazier J, et alCOVID-19 in children with haematological malignanciesArchives of Disease in Childhood 202
Chou, J., Thomas, P.G. & Randolph, A.G. Immunology of SARS-CoV-2 infection in children. Nat Immunol 23, 177–185 (2022). htt

Francesco Pegoraro, Sandra Trapani, Giuseppe Indolfi, Gastrointestinal, hepatic and pancreatic manifestations of COVID-19 in
2022,
101818,
ISSN 2210-7401,
https://doi.org/10.1016/j.clinre.2021.101818.
Mane SS, Janardhanan J, Pustake M, Wanvat A, Khan GI, Chopade R. Outcome of COVID-19 in Children With Tuberculosis: Sing
Yazdanpanah N, Rezaei N. Autoimmune complications of COVID-19. J Med Virol. 2022 Jan;94(1):54-62. doi: 10.1002/jmv.2729
th, 58: 39-45. https://doi.org/10.1111/jpc.15791
Health, 58: 46-53. https://doi.org/10.1111/jpc.15811